Aprocitentan 25 mg
Aprocitentan 25 mg is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
0
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension
To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women
Clinical Trials (4)
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension
To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4